Insider Selling: Plexus (NASDAQ:PLXS) CEO Sells $379,155.00 in Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd Kelsey sold 1,500 shares of Plexus stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $252.77, for a total transaction of $379,155.00. Following the completion of the sale, the chief executive officer directly owned 72,388 shares in the company, valued at $18,297,514.76. This trade represents a 2.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $265.72 on Monday. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The stock has a fifty day simple moving average of $230.26 and a two-hundred day simple moving average of $190.48. Plexus Corp. has a 1-year low of $115.35 and a 1-year high of $275.83. The firm has a market cap of $7.11 billion, a price-to-earnings ratio of 38.85 and a beta of 0.88.

Plexus (NASDAQ:PLXS) last issued its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The firm had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same period in the previous year, the company posted $1.66 earnings per share. The business’s revenue was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Analysts anticipate that Plexus Corp. will post 5.98 earnings per share for the current year.

Key Stories Impacting Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Zacks Research raised its earnings estimates for Plexus across several future periods, including FY2026, FY2027, FY2028 and multiple quarterly forecasts. Higher EPS expectations can support the stock by signaling stronger profit growth ahead. Plexus earnings estimate updates
• Positive Sentiment: The company’s recent quarterly results were solid, with Plexus beating EPS and revenue estimates and posting 18.7% year-over-year revenue growth, which continues to reinforce a constructive growth outlook.
• Neutral Sentiment: CEO Todd Kelsey sold 1,500 shares in a pre-arranged Rule 10b5-1 plan. The sale was relatively small versus his remaining stake, but insider selling can still weigh on sentiment. SEC Form 4 filing
• Negative Sentiment: Zacks Research also reiterated a “Strong Sell” rating on Plexus, creating a bearish counterpoint to the higher earnings estimates and potentially limiting upside. Zacks downgrade

Institutional Investors Weigh In On Plexus

Several hedge funds and other institutional investors have recently modified their holdings of PLXS. Covestor Ltd boosted its position in shares of Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after acquiring an additional 162 shares during the period. Allworth Financial LP increased its holdings in Plexus by 70.1% during the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after acquiring an additional 103 shares during the period. Johnson Financial Group Inc. bought a new stake in Plexus during the 3rd quarter worth approximately $72,000. Farther Finance Advisors LLC lifted its stake in Plexus by 114.7% in the 4th quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock worth $75,000 after purchasing an additional 273 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Plexus by 583.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after purchasing an additional 490 shares during the period. 94.45% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Stifel Nicolaus set a $250.00 price objective on shares of Plexus and gave the stock a “buy” rating in a report on Monday, April 20th. Needham & Company LLC lifted their price objective on shares of Plexus from $206.00 to $285.00 and gave the company a “buy” rating in a research note on Friday, May 1st. Benchmark reissued a “buy” rating and set a $220.00 target price on shares of Plexus in a report on Monday, March 16th. Finally, Williams Trading set a $195.00 target price on Plexus in a research report on Wednesday, January 28th. Five investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Plexus has an average rating of “Moderate Buy” and an average target price of $229.17.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.